Plasmodium phospholipid metabolism, a target for the development of novel antimalarial drugs.

被引：0

|

作者：

Vial, H

机构：

来源：

TROPICAL MEDICINE & INTERNATIONAL HEALTH | 1996年 / 1卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

收藏

页码：A19 / A20

页数：2

相关论文

共 50 条

[21] Is haemozoin a target for antimalarial drugs?
Meshnick, SR
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1996, 90 (04): : 367 - 372
[22] 6-Oxopurine Phosphoribosyltransferase: A Target for the Development of Antimalarial Drugs
De Jersey, John
Holy, Antonin
Hockova, Dana
Naesens, Lieve
Keough, Dianne T.
Guddat, Luke W.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (16) : 2085 - 2102
[23] Metalloaminopeptidases of the Protozoan Parasite Plasmodium falciparum as Targets for the Discovery of Novel Antimalarial Drugs
Mills, Belinda
Isaac, R. Elwyn
Foster, Richard
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (04) : 1763 - 1785
[24] Antimalarial drugs and glucose metabolism
Davis, TME
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (01) : 1 - 7
[25] In vivo antimalarial activities of mono- and bis quaternary ammonium salts interfering with Plasmodium phospholipid metabolism
Ancelin, ML
Calas, M
Bonhoure, A
Herbute, S
Vial, HJ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (08) : 2598 - 2605
[26] Plasmodium chabaudi:: Effect of antimalarial drugs on gametocytogenesis
Buckling, A
Crooks, L
Read, A
EXPERIMENTAL PARASITOLOGY, 1999, 93 (01) : 45 - 54
[27] Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs
Hyde, JE
MICROBES AND INFECTION, 2002, 4 (02) : 165 - 174
[28] Understanding the biology of the Plasmodium falciparum apicoplast; an excellent target for antimalarial drug development
Chakraborty, Arnish
LIFE SCIENCES, 2016, 158 : 104 - 110
[29] The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum
Le Bras, J
Durand, R
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2003, 17 (02) : 147 - 153
[30] Data mining analysis of psychosis with mefloquine and other antimalarial drugs.
Coster, TS
Szarfman, A
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P77 - P77

← 1 2 3 4 5 →